JP2024500313A5 - - Google Patents

Info

Publication number
JP2024500313A5
JP2024500313A5 JP2023534101A JP2023534101A JP2024500313A5 JP 2024500313 A5 JP2024500313 A5 JP 2024500313A5 JP 2023534101 A JP2023534101 A JP 2023534101A JP 2023534101 A JP2023534101 A JP 2023534101A JP 2024500313 A5 JP2024500313 A5 JP 2024500313A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
variable region
chain variable
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534101A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/072723 external-priority patent/WO2022120375A1/en
Publication of JP2024500313A publication Critical patent/JP2024500313A/ja
Publication of JP2024500313A5 publication Critical patent/JP2024500313A5/ja
Pending legal-status Critical Current

Links

JP2023534101A 2020-12-04 2021-12-03 コロナウイルス感染の検出および治療のためのポリペプチド Pending JP2024500313A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063121384P 2020-12-04 2020-12-04
US63/121,384 2020-12-04
PCT/US2021/072723 WO2022120375A1 (en) 2020-12-04 2021-12-03 Polypeptides for detection and treatment of coronavirus infection

Publications (2)

Publication Number Publication Date
JP2024500313A JP2024500313A (ja) 2024-01-09
JP2024500313A5 true JP2024500313A5 (cg-RX-API-DMAC7.html) 2024-12-06

Family

ID=81853577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534101A Pending JP2024500313A (ja) 2020-12-04 2021-12-03 コロナウイルス感染の検出および治療のためのポリペプチド

Country Status (4)

Country Link
US (1) US20240002477A1 (cg-RX-API-DMAC7.html)
EP (1) EP4255487A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024500313A (cg-RX-API-DMAC7.html)
WO (1) WO2022120375A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039597B2 (en) * 2007-09-07 2011-10-18 Agensys, Inc. Antibodies and related molecules that bind to 24P4C12 proteins
UA109888C2 (uk) * 2009-12-07 2015-10-26 ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
WO2013059524A2 (en) * 2011-10-18 2013-04-25 Emory University Antibodies directed against influenza
KR102520731B1 (ko) * 2016-09-23 2023-04-14 리제너론 파아마슈티컬스, 인크. 항-steap2 항체, 항체-약물 컨쥬게이트, 및 steap2 및 cd3에 결합하는 이중특이적 항원-결합 분자, 및 이의 용도
CR20220552A (es) * 2020-04-02 2023-01-17 Regeneron Pharma Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno

Similar Documents

Publication Publication Date Title
CN112585165B (zh) 优化的抗tl1a抗体
JP2021526022A5 (cg-RX-API-DMAC7.html)
CN104936981B (zh) Il‑17a结合物及其用途
WO2019062832A1 (zh) Tigit抗体、其抗原结合片段及医药用途
CN119552248A (zh) B7-h4抗体及其使用方法
RU2020130795A (ru) Нейтрализующие антитела к env вич-1 и их применение
JP2022122865A5 (cg-RX-API-DMAC7.html)
CN106565840B (zh) 抗乙肝表面抗原的抗体及其用途
CN114829395A (zh) 抗angptl3抗体及其应用
CN105745225A (zh) Nav1.7抗体和使用所述抗体的方法
CN113840836B (zh) 抗结缔组织生长因子抗体及其应用
CN110461874B (zh) 抗gitr抗体、其抗原结合片段及其医药用途
CN118165106A (zh) 抗犬il-31单克隆抗体及其应用
JP2025505650A5 (cg-RX-API-DMAC7.html)
CN112969715B (zh) 一种抗cd47抗原结合蛋白及其应用
CN114957468A (zh) 一种抗Siglec15抗体及其用途
US20220380446A1 (en) Antibodies for treating alpha-synucleinopathies
CN118667002A (zh) 抗cd27单克隆抗体及其应用
JP2024536358A5 (cg-RX-API-DMAC7.html)
JP2024509369A (ja) 抗pd-l1抗体及びその使用
WO2024088342A1 (en) Antibodies against cd24 and uses thereof
CN116284406B (zh) 一种pd-1结合蛋白及其应用
US20250353928A1 (en) Antibodies and antibody fragments that bind ige
KR20250005309A (ko) 인터루킨-19를 표적으로 삼는 항체 및 표적 방법
TW202521573A (zh) Gdf15中和抗體及其用途